US-based health technology company DexCom has introduced Dexcom ONE+, its new real-time continuous glucose monitoring (CGM) system for people with Type 1 or Type 2 diabetes.
Dexcom ONE+ is designed to leverage the company’s most accurate sensor design and is developed using feedback from both end users and healthcare professionals.
The new CGM system is currently available in Spain, Belgium, and Poland, with plans to launch in the Netherlands next week, and additional countries in the coming months.
Dexcom ONE+ would replace the previous generation Dexcom ONE sensor in some countries, said the company.
Dexcom executive vice president and chief commercial officer Teri Lawver said: “Dexcom ONE+ incorporates our best-in-class technology and a range of features that we know will be well-received by the diabetes community.
“By building Dexcom ONE+ based on user and healthcare professional feedback we know we have a CGM system that is flexible, easy to get started with, and intuitive to use; a system that people with either Type 1 or Type 2 diabetes, and their care teams, can benefit from.”
According to Dexcom, people who manage diabetes using finger pricks and regularly inject insulin may feel suppressed by the disease.
The Dexcom ONE+, which is easy to get started with and easy to live with, even for those with no experience of using a CGM system, is designed to reduce the disease burden.
The device provides a clear picture of glucose levels in real time without painful finger pricks and allows users to easily share their glucose numbers with up to ten people.
Unlike other CGM systems, the new Dexcom ONE+ CGM system on its multiple possibilities for personalisation and flexibility.
It provides three wear location options and is the only CGM system to offer a ‘delay first high’ option, a customisable feature that allows a user to prevent alert fatigue.
Dexcom ONE+ also has the highest waterproof rating than other CGM brands, which allows the patients to use their device while showering or exercising, said the medical device firm.
Dexcom EMEA and LATAM senior vice president and general manager Alex Moussa said: “Dexcom ONE+ continues the work of Dexcom ONE in bringing access to our life-changing technology to millions of people across Europe, the Middle East and Africa.
“Through our ongoing innovation and product development, not only are we bringing the best, and most accurate, version of our technology to even more people, but we continue to show our commitment to significantly expanding access to CGM for people with all types of diabetes.”
